Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng-Ping Li

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Journal of Advanced Research|September 13, 2022
Cisplatin and gemcitabine exert opposite effects on immunotherapy with PD-1 antibody in K-ras-driven cancerChristophe Glorieux, Xiaojun Xia, Xin You, et al.
Oncotarget|May 21, 2014
Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcomaKaishun Hu, Dan Liao, Wenjing Wu, et al.
The Lancet. Oncology|June 20, 2015
A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control studyXue-Jia Lin, Yutian Chong, Zhi-Wei Guo, et al.
Annals of Surgical Oncology|July 30, 2013
The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patientsKe Pan, Yong-Qiang Li, Wei Wang, et al.
Leukemia|December 20, 2024
Genetic susceptibility of diffuse large B-cell lymphoma: a meta genome-wide association study in Asian populationQian Cui, Wen Tan, Bao Song, et al.
Nature Communications|June 2, 2015
Identification of new susceptibility loci for IgA nephropathy in Han ChineseMing Li, Jia-Nee Foo, Jin-Quan Wang, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Journal of Advanced Research|September 13, 2022
Cisplatin and gemcitabine exert opposite effects on immunotherapy with PD-1 antibody in K-ras-driven cancerChristophe Glorieux, Xiaojun Xia, Xin You, et al.
Oncotarget|May 21, 2014
Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcomaKaishun Hu, Dan Liao, Wenjing Wu, et al.
The Lancet. Oncology|June 20, 2015
A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control studyXue-Jia Lin, Yutian Chong, Zhi-Wei Guo, et al.
Annals of Surgical Oncology|July 30, 2013
The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patientsKe Pan, Yong-Qiang Li, Wei Wang, et al.
Leukemia|December 20, 2024
Genetic susceptibility of diffuse large B-cell lymphoma: a meta genome-wide association study in Asian populationQian Cui, Wen Tan, Bao Song, et al.
Nature Communications|June 2, 2015
Identification of new susceptibility loci for IgA nephropathy in Han ChineseMing Li, Jia-Nee Foo, Jin-Quan Wang, et al.
Pageof 6